Medical Examiner Employees Indicted in Investigation into Compro - WBOC-TV 16, Delmarvas News Leader, FOX 21 -

Medical Examiner Employees Indicted in Investigation into Compromised Drug Evidence


WILMINGTON, Del.- Two employees of the Office of the Chief Medical Examiner were charged with indictments Wednesday for multiple offenses, according to Attorney General Beau Biden. The indictments come as a result of an ongoing criminal investigation into compromised drug evidence in the OCME’s Controlled Substance Lab.

Officials said that 38-year-old James Woodson of Wilmington, was indicted on one count each of trafficking cocaine, theft of a controlled substance, official misconduct, and tampering with evidence for allegedly removing cocaine from an evidence bag at the Controlled Substances Lab.

In addition, he was charged with a violation of the Delaware Criminal Justice Information System for violating terms of use governing his access to the database in April 2014.

The other man, 54-year-old Farnam Daneshgar also of Wilmington, was indicted on two counts of falsifying business records for allegedly failing to produce reports documenting discrepancies in drug evidence he reviewed in two cases. Officials said he was also charged with possession of marijuana and possession of drug paraphernalia related to evidence seized during a search warrant at his home.

“With these indictments we are beginning to hold individuals accountable for the significant damage that has been caused to the integrity of our criminal justice system,” Biden said.

Delaware State Police arrested both men. They were arraigned in New Castle County Superior Court. Bail amounts were set at $20,000 for Woodson, and $5,000 secured for Daneshgar, according to officials.

Because the criminal investigation is ongoing no additional information about the investigation is being released at this time.

Powered by Frankly

All content © Copyright 2000 - 2018 WBOC. All Rights Reserved. For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices